PLA2G7 and cardiovascular disorder: Although circulating lipoprotein-associated phospholipase A(2) (Lp-PLA2) has been considered as novel biomarker for cardiovascular diseases, its correlation between the atherosclerotic plaque expression of Lp-PLA2, inflammation, stability and the presence of clinical symptoms, especially for cerebrovascular disease, remains poorly defined.